Literature DB >> 20859617

An examination of NMDA receptor contribution to conditioned responding evoked by the conditional stimulus effects of nicotine.

Jennifer E Murray1, Andrew W Walker, Robert J Polewan, Rick A Bevins.   

Abstract

RATIONALE: Research using a drug discriminated goal-tracking (DGT) task showed that the N-methyl-D: -aspartate (NMDA) channel blocker MK-801 (dizocilpine) reduced the nicotine-evoked conditioned response (CR).
OBJECTIVES: Given the unknown mechanism of the effect, Experiment 1 replicated the MK-801 results and included tests with NMDA receptor ligands. Experiments 2a and 2b tested whether MK-801 pretreatment blocked DGT via a state-dependency effect.
METHODS: In Experiment 1, adult male Sprague-Dawley rats received intermittent access to liquid sucrose following nicotine (0.4 mg base/kg); no sucrose was delivered on intermixed saline sessions. Conditioning was indicated by increased anticipatory dipper entries (goal-tracking) on nicotine compared to saline sessions. Antagonism and/or substitution tests were conducted with MK-801, phencyclidine, CGP 39551, d-CPPene (SDZ EAA 494), Ro 25,6981, L-701,324, ACPC, and NMDA. In Experiment 2a, rats received nicotine and sucrose on every session-no intermixed saline sessions without sucrose. Tests combined MK-801 or the non-competitive nicotinic acetylcholine receptor antagonist, mecamylamine with either nicotine or saline. Experiment 2b had sucrose delivered on saline sessions and no sucrose on intermixed nicotine sessions followed by MK-801 antagonism tests of the saline CS.
RESULTS: MK-801 and phencyclidine dose-dependently attenuated the CR in Experiment 1. Ro-25,6981 enhanced the CR, but did not substitute for nicotine. Other ligands showed inconsistent effects. In Experiment 2a, MK-801 pretreatment reduced goal-tracking when given before nicotine and saline test sessions; mecamylamine pretreatment had no effect. In Experiment 2b, MK-801 dose-dependently attenuated the saline-evoked CR.
CONCLUSIONS: Combined, the results suggest that MK-801 blocks discriminated goal-tracking by virtue of state-changing properties.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20859617      PMCID: PMC3028533          DOI: 10.1007/s00213-010-2022-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  57 in total

Review 1.  Neuropharmacology of the interoceptive stimulus properties of nicotine.

Authors:  Thomas E Wooters; Rick A Bevins; Michael T Bardo
Journal:  Curr Drug Abuse Rev       Date:  2009-09

Review 2.  Extending the role of associative learning processes in nicotine addiction.

Authors:  Rick A Bevins; Matthew I Palmatier
Journal:  Behav Cogn Neurosci Rev       Date:  2004-09

3.  Using drug-discrimination techniques to study the abuse-related effects of psychoactive drugs in rats.

Authors:  Marcello Solinas; Leigh V Panlilio; Zuzana Justinova; Sevil Yasar; Steven R Goldberg
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

4.  Interoceptive Pavlovian conditioning with nicotine as the conditional stimulus varies as a function of the number of conditioning trials and unpaired sucrose deliveries.

Authors:  Jamie L Wilkinson; Jennifer E Murray; Chia Li; Steven M Wiltgen; Rachel D Penrod; Sarah A Berg; Rick A Bevins
Journal:  Behav Pharmacol       Date:  2006-03       Impact factor: 2.293

Review 5.  The glycine site of the NMDA receptor--five years on.

Authors:  J A Kemp; P D Leeson
Journal:  Trends Pharmacol Sci       Date:  1993-01       Impact factor: 14.819

6.  Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.

Authors:  Alexander R Kosowski; Gvido Cebers; Aleta Cebere; Ann-Charlott Swanhagen; Sture Liljequist
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

7.  The conditional stimulus effects of nicotine vary as a function of training dose.

Authors:  Jennifer E Murray; Rick A Bevins
Journal:  Behav Pharmacol       Date:  2007-12       Impact factor: 2.293

8.  The glycine/NMDA receptor antagonist, L-701,324 reverses isolation-induced deficits in prepulse inhibition in the rat.

Authors:  L J Bristow; L Landon; K L Saywell; M D Tricklebank
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

Review 9.  Altering the motivational function of nicotine through conditioning processes.

Authors:  Rick A Bevins
Journal:  Nebr Symp Motiv       Date:  2009

10.  Nicotine as a signal for the presence or absence of sucrose reward: a Pavlovian drug appetitive conditioning preparation in rats.

Authors:  Joyce Besheer; Matthew I Palmatier; Dawn M Metschke; Rick A Bevins
Journal:  Psychopharmacology (Berl)       Date:  2003-10-03       Impact factor: 4.530

View more
  4 in total

Review 1.  Disentangling the nature of the nicotine stimulus.

Authors:  Rick A Bevins; Scott T Barrett; Robert J Polewan; Steven T Pittenger; Natashia Swalve; Sergios Charntikov
Journal:  Behav Processes       Date:  2011-11-24       Impact factor: 1.777

2.  Conditioned response evoked by nicotine conditioned stimulus preferentially induces c-Fos expression in medial regions of caudate-putamen.

Authors:  Sergios Charntikov; Matthew E Tracy; Changjiu Zhao; Ming Li; Rick A Bevins
Journal:  Neuropsychopharmacology       Date:  2011-11-02       Impact factor: 7.853

3.  The effect of sazetidine-A and other nicotinic ligands on nicotine controlled goal-tracking in female and male rats.

Authors:  S Charntikov; A M Falco; K Fink; L P Dwoskin; R A Bevins
Journal:  Neuropharmacology       Date:  2016-10-17       Impact factor: 5.250

4.  Nicotine trained as a negative feature passes the retardation-of-acquisition and summation tests of a conditioned inhibitor.

Authors:  Jennifer E Murray; Andrew W Walker; Chia Li; Nicole R Wells; Rachel D Penrod; Rick A Bevins
Journal:  Learn Mem       Date:  2011-06-21       Impact factor: 2.460

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.